A gender stratified controlled descriptive study to identify how specific food and drink consumption differentiate in MS

Main Article Content

Gülşen Delikanlı Akbay https://orcid.org/0000-0003-1366-4685
Erdinç Karakullukçu https://orcid.org/0000-0001-8805-1694
Aslı Akyol Mutlu https://orcid.org/0000-0001-6301-6358


Multiple sclerosis, food and drink consumption, sleeping duration, obesity, logistic regression.


Objective: There is an ongoing research on the idea that certain diets could make a difference in Multiple Sclerosis (MS) symptoms and progression. This study aimed to investigate the consumption rates of certain food and drinks in MS patients. The association between the presence of MS and the body mass index, sleeping duration, obesity status was also examined.

Methods: The study was designed as a controlled descriptive study, consisting of 229 females (134 MS patients, 95 healthy volunteers) and 163 males (62 MS patients, 101 healthy volunteers). Blood samples were collected for biochemical evaluation of 25-hydroxyvitamin D (25(OH)D). Obesity status of the participants was determined. Average 24-hour retrospective food and drink consumption rates were collected. To identify factors associated with MS, multivariate logistic regression analyses were applied for both male and female data.

Results: Increase in 25(OH)D level was associated with decrease in the odds of having MS. Women were more likely to experience MS if they preferred to wear head and body-covering clothes in their daily lives. For both male and females, increase in the individual consumption rate of herbal tea and coffee was associated with a reduction in the likelihood of having MS. Moreover, men who sleep half an hour more in a day were 16.5% less likely to have MS, adjusted for other factors considered in this study.

Conclusion: Based on the findings of this study, nutrition contents of the food and drinks associated with MS can be detected, and dietary precautions might be taken.

Abstract 267 | PDF Downloads 195


1. World Health Organization (WHO). Neurological disorders: Public health challenges. 2006: Geneva.
2. Kingwell K. Disease mechanisms in MS: Informing tactics to combat MS. Nat Rev Neurol. 2012; 8: 589.
3. Tullman MJ. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care. 2013; 19: 15-20.
4. Rotstein Z, Hazan R, Barak Y, Achiron A. Perspectives in multiple sclerosis health care: Special focus on the costs of multiple sclerosis. Autoimmunirty Rev. 2006; 5: 511-516.
5. Al-Omaishi J, Bashir R, Gendelman HE. The cellular immunology of multiple sclerosis. J Leukoc Biol. 1999; 65: 444-452.
6. Schmitz K, Barthelmes J, Stolz L, Beyer S, Diehl O, Tegeder I. Disease modifying nutricals for multiple sclerosis. Pharmacol Ther. 2015; 148: 85-113.
7. Compston A, Coles A. Multiple sclerosis. Lancet. 2002; 359: 1221-1231.
8. VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: An update. Eur J Clin Nutr. 2004; 58: 1095-1109.
9. Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015; 7: 1759091414568185.
10. Sand IK. The role of diet in multiple sclerosis: Mechanistic connections and current evidence. Curr Nutr Rep. 2018; 7: 150-160.
11. Ghadirian P, Jain M, Ducic S, Shatenstein B, Morisset R. Nutritional factors in the aetiology of multiple sclerosis: a case- control study in Montreal, Canada. Int J Epidemiol. 1998; 27: 845-852.
12. Zhang SM, Willett WC, Hernán MA, Olek MJ, Ascherio A. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol. 2000; 152: 1056-1064.
13. Tola MR, Granieri E, Malagu S, Caniatti L, Casetta I, Govoni V, et al. Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy. Acta Neurol (Napoli). 1994; 16: 189-197.
14. Schwarz S, Knorr C, Geiger H, Flachenecker P. Complementary and alternative medicine for multiple sclerosis. Mult Scler. 2008; 14: 1113-1119.
15. World Health Organization (WHO). International classification of functioning, disability and health: ICF. 2001: Geneva.
16. Grant WB. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr. 2011; 65: 1016-1026.
17. Khosravi-Largani M, Pourvali-Talatappeh P, Rousta AM, Karimi-Kivi M, Noroozi E, Mahjoob A, et al. A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis. eNeurologicalSci. 2018; 10: 37-1044.
18. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2017; 2: 989-1024.
19. Haq A, Svobodová J, Imran S, Stanford C, Razzaque MS. Vitamin D deficiency: a single centre analysis of patients from 136 countries. J Steroid Biochem Mol Biol. 2016; 164: 209-213.
20. Elsammak MY, Al-Wosaibi AA, Al-Howeish A, Alsaeed J. Vitamin D deficiency in Saudi Arabs. Horm Metab Res. 2010; 42: 364-368.
21. Kim S, Chang L, Weinstock-Guttman B, Gandhi S, Jakimovski D, Carl E, et al. Complementary and alternative medicine usage by multiple sclerosis patients: Results from a prospective clinical study. J Altern Complement Med. 2018; 24: 596-602.
22. Skovgaard L, Nicolajsen PH, Pedersen E, Kant M, Fredrikson S, Verhoef M, et al. Use of complementary and alternative medicine among people with multiple sclerosis in the Nordic countries. Autoimmune Dis. 2012; 2012: 841085.
23. Mojaverrostami S, Bojnordi MN, Ghasemi-Kasman M, Ebrahimzadeh MA, Hamidabadi HG. A review of herbal therapy in multiple sclerosis. Adv Pharm Bull. 2018; 8: 575-590.
24. Kim J, Lee KW. Coffee and its active compounds are neuroprotective. In Preedy VR, editor: Coffee in health and disease prevention. Academic Press; 2015. p. ;423-427.
25. Hedström AK, Mowry EM, Gianfrancesco MA, Shao X, Schaefer CA, Shen L, et al. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies. J Neurol Neurosurg Psychiatry. 2016; 87: 454-460.
26. D’hooghe MB, Haentjens P, Nagels G, De Keyser J. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol. 2012; 19: 616-624.
27. Natarajan C, Bright JJ. Curcumin Inhibits Experimental Allergic Encephalomyelitis by Blocking IL-12 Signaling Through Janus Kinase-STAT Pathway in T Lymphocytes. J Immunol. 2002; 168(12): 6506-6513.
28. Mähler A, Steiniger J, Bock M, Klug L, Parreidt N, Lorenz M, et al. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: A randomized clinical trial. Am J Clin Nutr. 2015; 101: 487-495.
29. Aktas O, Prozorovski T, Smorodchenko A, Savaskan NE, Lauster R, Kloetzel PM, et al. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J Immunol. 2004; 173: 5794-5800.
30. Naziroglu M, Kutluhan S, Ovey IS, Aykur M, Yurekli VA. Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis by Hypericum perforatum . Nutr Neurosci. 2014; 17: 214-221.
31. Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, et al. Diet quality is associated with disability and symptom severity in multiple sclerosis. Neurology. 2018; 90: e1-11.
32. Pekmezovic TD, Tepavcevic DBK, Mesaros ST, Basuroski IBD, Stojsavljevic NS, Drulovic JS. Food and dietary patterns and multiple sclerosis: a case-control study in Belgrade (Serbia). Ital J Public Health. 2012; 6: 81-87.
33. Sepcić J, Mesaros E, Materljan E, Sepić-Grahovac D. Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia. Neuroepidemiology. 1993;12:234-240.
34. Bagheri M, Maghsoudi Z, Fayazi S, Elahi N, Tabesh H. Several food items and multiple sclerosis : A case-control study in Ahvaz ( Iran ) Background : Materials and Methods : Results : Conclusions : 2018; 19(6): 659-665.
35. Merlino G, Fratticci L, Lenchig C, Valente M, Cargnelutti D, Picello M, et al. Prevalence of ‘poor sleep’ among patients with multiple sclerosis: An independent predictor of mental and physical status. Sleep Med. 2009; 10: 26-34.
36. Bamer AM, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multplie sclerosis. Mult Scler. 2008; 14: 1127-1030.
37. Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr KM, et al. Poor sleep in patients with multiple sclerosis. PLoS One. 2012; 7: e49996.
38. Pokryszko-Dragan A, Bilińska M, Gruszka E, Biel Ł, Kamińska K, Konieczna K. Sleep disturbances in patients with multiple sclerosis. Neurol Sci. 2013; 34: 1291-1296.
39. Veauthier C, Radbru H, Gaede G, Pfueller CF, Dörr J, Bellmann-Strobl J, et al. Fatigue in multiple sclerosis is closely related to sleep disorders: A polysomnographic cross-sectional study. Mult Scler. 2011; 17: 613-622.
40. Kingwell E, Marriott JJ, Jetté N, Pringsheim T, Makhani N, Morrow SA, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013; 13: 128.